SANTUS, PIERACHILLE
 Distribuzione geografica
Continente #
EU - Europa 11.170
NA - Nord America 7.798
AS - Asia 4.505
SA - Sud America 175
OC - Oceania 136
AF - Africa 82
Continente sconosciuto - Info sul continente non disponibili 24
Totale 23.890
Nazione #
US - Stati Uniti d'America 7.533
GB - Regno Unito 5.115
IT - Italia 2.174
CN - Cina 1.854
SG - Singapore 975
DE - Germania 810
SE - Svezia 742
RU - Federazione Russa 518
IN - India 410
IE - Irlanda 383
FR - Francia 323
KR - Corea 299
TR - Turchia 245
CA - Canada 243
DK - Danimarca 195
FI - Finlandia 179
UA - Ucraina 160
ID - Indonesia 152
NL - Olanda 129
HK - Hong Kong 119
AU - Australia 116
JP - Giappone 106
EU - Europa 83
VN - Vietnam 83
GR - Grecia 75
TH - Thailandia 63
BR - Brasile 62
CO - Colombia 57
CH - Svizzera 53
BE - Belgio 52
ES - Italia 52
PH - Filippine 40
TW - Taiwan 36
NO - Norvegia 32
PL - Polonia 32
RO - Romania 30
MY - Malesia 29
EG - Egitto 24
ZA - Sudafrica 21
AT - Austria 20
NZ - Nuova Zelanda 20
IR - Iran 19
CL - Cile 18
PT - Portogallo 18
IL - Israele 15
AR - Argentina 14
PE - Perù 13
PK - Pakistan 12
CZ - Repubblica Ceca 11
MX - Messico 11
BG - Bulgaria 10
SA - Arabia Saudita 10
HU - Ungheria 9
LT - Lituania 9
ET - Etiopia 8
RS - Serbia 8
AE - Emirati Arabi Uniti 7
HR - Croazia 7
DZ - Algeria 6
GH - Ghana 6
LB - Libano 6
NP - Nepal 6
SC - Seychelles 6
GT - Guatemala 5
BA - Bosnia-Erzegovina 4
EC - Ecuador 4
SI - Slovenia 4
A1 - Anonimo 3
A2 - ???statistics.table.value.countryCode.A2??? 3
BD - Bangladesh 3
CU - Cuba 3
EE - Estonia 3
IQ - Iraq 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
VE - Venezuela 3
AL - Albania 2
BO - Bolivia 2
KH - Cambogia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
LV - Lettonia 2
MA - Marocco 2
MK - Macedonia 2
QA - Qatar 2
UG - Uganda 2
UY - Uruguay 2
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
AZ - Azerbaigian 1
BS - Bahamas 1
CY - Cipro 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LY - Libia 1
MD - Moldavia 1
MU - Mauritius 1
Totale 23.952
Città #
Southend 4.855
Chandler 774
Singapore 729
Milan 637
Fairfield 596
Seattle 460
Ashburn 438
Wilmington 424
Princeton 401
Dublin 375
Houston 333
Woodbridge 325
Ann Arbor 313
Beijing 247
Boardman 239
Santa Clara 216
Portland 213
Cambridge 211
Toronto 168
Dearborn 150
Des Moines 129
Bengaluru 127
Nanjing 126
Mountain View 116
Seoul 110
Frankfurt am Main 107
Jakarta 107
Jacksonville 99
Shanghai 94
Redmond 93
Redwood City 92
Guangzhou 81
Hanover 76
Helsinki 76
New York 73
Berlin 69
Hong Kong 68
Shenyang 62
Sakarya 59
San Diego 58
Athens 56
Jinan 56
Rome 56
Phoenix 52
Munich 51
Grafing 45
Serra 43
Nanchang 42
Tokyo 41
Bogotá 40
Somerville 40
Istanbul 39
Turin 39
Hebei 35
Andover 34
Tianjin 33
Chicago 32
Changsha 31
London 31
Hanoi 29
Bangkok 28
Bühl 28
Fremont 26
Hangzhou 26
Saint Petersburg 26
Eitensheim 25
Lanzhou 25
Silver Spring 25
Brussels 24
Taipei 24
Los Angeles 23
Nuremberg 23
Piscataway 23
Fuzhou 22
Central District 21
Duncan 21
Jiaxing 21
Melbourne 21
Ottawa 21
Warsaw 21
Washington 21
Zhengzhou 20
Bangalore 19
Chengdu 19
Hefei 19
Falls Church 18
Kent 18
Monza 18
Mumbai 18
Wuhan 18
Como 17
Kuala Lumpur 16
Paris 16
Central 15
Haikou 15
Pune 15
Scranton 15
Daejeon 14
Norwalk 14
Sydney 14
Totale 15.564
Nome #
Early management of COPD : Where are we now and where do we go from here? a delphi consensus project 550
Long-acting bronchodilators improve exercise capacity in COPD patients : a systematic review and meta-analysis 517
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial 511
Indirect and Direct Effects of SARS-CoV-2 on Human Pancreatic Islets 430
Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study 398
Stress ossidativo nella s. di Down : determinazione dell'8-isoprostano nell'esalato, nel siero e nelle urine 336
Enviromental pollution and emergency department admission for respiratory and cardiovascular diseases in Milan Italy. The POEMI project 292
The Relevance of Targeting Treatment to Small Airways in Asthma and COPD 274
Assessment of acute bronchodilator effects from specific airway resistance changes in stable COPD patients 269
Lipid peroxidation and 5-lipoxygenase activity in chronic obstructive pulmonary disease 243
5-Lipoxygenase activity, lipid peroxidation and the effect of antioxidant treatment in COPD subjects 227
How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group 226
Mild/Moderate Asthma Network in Italy (MANI): a long-term observational study 226
Expiratory flow-limitation and heliox breathing in resting and exercising COPD patients 219
Manifesto on united airways diseases (UAD): an Interasma (global asthma association - GAA) document 216
Effect of indacaterol on lung deflation improves cardiac performance in hyperinflated COPD patients : an interventional, randomized, double-blind clinical trial 203
How air pollution influences clinical management of respiratory diseases. A case-crossover study in Milan 202
Avoiding misdiagnosis in patients with dyspnea and wheezing : a case report illustrating the clinical implications of fixation error 202
Effect of enalapril on exercise cardiopulmonary performance in chronic obstructive pulmonary disease : a pilot study 200
The airways' mechanical stress in lung disease: Implications for COPD pathophysiology and treatment evaluation 198
Disease awareness in patients with COPD: measurement and extent 191
Psoriasis and Respiratory Comorbidities : the Added Value of Fraction of Exhaled Nitric Oxide as a New Method to Detect, Evaluate, and Monitor Psoriatic Systemic Involvement and Therapeutic Efficacy 188
Bronchodilation test in COPD : effect of inspiratory manoeuvre preceding forced expiration 182
Severity of respiratory failure at admission and in-hospital mortality in patients with COVID-19: a prospective observational multicentre study 177
Characteristics and treatment regimens across ERS SHARP severe asthma registries 176
Airway occlusion assessed by single breath N2 test and lung P-V curve in healthy subjects and COPD patients 174
Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of anti-infective therapy (SITA) and the Italian Society of Pulmonology (SIP) 173
Oxidative stress and viral Infections: rationale, experiences, and perspectives on N-acetylcysteine 171
Azithromycin and lower respiratory tract infections 169
An international perspective on hospitalized patients with viral community-acquired pneumonia 168
What drives inhaler prescription for asthma patients? Results from a real-life retrospective analysis 164
Pulmonary rehabilitation in COPD : a reappraisal (2008-2012) 161
Improvements in Lung Diffusion Capacity following Pulmonary Rehabilitation in COPD with and without Ventilation Inhomogeneity 160
Role of nebulized glycopyrrolate in the treatment of chronic obstructive pulmonary disease 160
A systematic review on tracheostomy decannulation: a proposal of a quantitative semiquantitative clinical score 158
Acute effects of higher than standard doses of salbutamol and ipratropium on tiotropium-induced bronchodilation in patients with stable COPD 157
Highlights on the appropriate use of fluoroquinolones in respiratory tract infections 157
Rhino-sinobronchial syndrome 157
Plethysmographic Loops : a Window on the Lung Pathophysiology of COPD Patients 157
The evidence on tiotropium bromide in asthma: from the rationale to the bedside 156
Characteristics, outcomes and global trends of respiratory support in patients hospitalized with COVID-19 pneumonia : a scoping review 156
Detection of expiratory flow limitation in COPD using the forced oscillation technique 152
The role of phenotype on ventilation and exercise capacity in patients affected by COPD : a retrospective study 151
Bronchodilation test in COPD : effect of inspiratory manoeuvre preceding forced expiration 150
Effects of salmeterol on cilia and mucus in COPD and Pneumonia patients 149
The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD 149
Management of severe COPD exacerbations : focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide 149
Anxiety and depression in asthma 146
Rapid On-Site Evaluation Improves Needle Aspiration Sensitivity in the Diagnosis of Central Lung Cancers : a Randomized Trial 145
Anti-inflammatory effects of immunostimulation in patients with covid-19 pneumonia 145
West Fisiopatologia polmonare : l'essenziale 144
Leukotriene synthesis and lipid peroxidation in COPD subjects 143
Acute effects of long acting bronchodilators on small airways detected in COPD patients by single breath N2 test and lung P-V curve 142
The functional impact of adding salmeterol and tiotropium in patients with stable COPD 141
Salmeterol/fluticasone propionate in a Single Inhaler Device versus theophylline þ fluticasone propionate in patients with COPD 141
Characteristics of newly diagnosed COPD patients treated with triple inhaled therapy by general practitioners : A real world Italian study 140
Tiotropium is less likely to induce oxygen desaturation in stable COPD patients compared to long-acting beta2-agonists 140
Anxiety and depression in COPD patients : the roles of gender and disease severity 139
A pilot study to assess the effects of combining fluticasone propionate/ salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPD 138
Formoterol fumarate + glycopyrrolate for the treatment of chronic obstructive pulmonary disease 138
Interventional pulmonology techniques in elderly patients with comorbidities 138
Salmeterol improves fluid clearance from alveolar-capillary membrane in COPD patients : A pilot study 137
Is mild asthma in real life always in the Green Zone? 137
Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis 136
Tidal expiratory flow-limitation induces expiratory looping of the alveolar pressure-flow relation in COPD patients 134
Biomarkers in obstructive respiratory diseases : an update 132
Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection 132
Severe asthma and long-term Benralizumab effectiveness in real-life 129
Helmet CPAP to Treat Acute Hypoxemic Respiratory Failure in Patients with COVID-19 : a Management Strategy Proposal 129
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life 129
Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD 128
Changes in quality of life and dyspnoea after hospitalization in COVID-19 patients discharged at home 127
Faster reduction in hyperinflation and improvement in lung ventilation inhomogeneity promoted by aclidinium compared to glycopyrronium in severe stable COPD patients. A randomized crossover study 126
Gender differences in asthma perception and its impact on quality of life : a post hoc analysis of the PROXIMA (Patient Reported Outcomes and Xolair® in the Management of Asthma) study 126
Cardiopulmonary exercise testing and second-line pulmonary function tests to detect obstructive pattern in symptomatic smokers with borderline spirometry 126
Effect of inhaled combination therapy on asthma management 125
Effects of aclidinium on determinants of COPD severity : symptoms and quality of life 123
Addition of an extra dose of salmeterol Diskus to conventional dose of salmeterol Diskus in patients with COPD 122
A single high dose of formoterol is as effective as the same dose administered in a cumulative manner in patients with acute exacerbation of COPD. 122
Onset of action of formoterol/budesonide in single inhaler vs. formoterol in patients with COPD 121
Tiotropium: what came after the UPLIFT study 121
A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management 121
Expiratory flow limitation and heliox breathing in resting and exercising COPD patients 120
Disability in moderate chronic obstructive pulmonary disease : prevalence, burden and assessment : results from a Real-Life Study 120
SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma 120
Choose the best route : ultrasound-guided transbronchial and transesophageal needle aspiration with echobronchoscope in the diagnosis of mediastinal and pulmonary lesions 119
Asthma management in a specialist setting : results of an Italian Respiratory Society survey 119
Effect of continuous positive airway pressure on respiratory drive in patients with obstructive sleep apnea 119
PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response 119
Asma bronchiale 118
Atopy prevalence and spirometric performance in asymptomatic schoolchildren exposed to air pollution. 118
Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease. 117
Effects of bronchodilation on biomarkers of peripheral airway inflammation in COPD 116
Dysphagia symptoms in obstructive sleep apnea : prevalence and clinical correlates 116
Predictors of Helmet CPAP Failure in COVID-19 Pneumonia: A Prospective, Multicenter, and Observational Cohort Study 116
Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia 115
Comparison of the acute effect of tiotropium versus a combination therapy with single inhaler budesonide/formoterol on the degree of resting pulmonary hyperinflation 113
Bronchodilators Modulate Inflammation In Chronic Obstructive Pulmonary Disease Subjects 113
Neutrophilic Dermatoses and Their Implication in Pathophysiology of Asthma and Other Respiratory Comorbidities: A Narrative Review 113
Bronchodilating effect of oxitropium bromide in heart disease patients with exacerbations of COPD: double-blind, randomized, controlled study. 112
Totale 17.117
Categoria #
all - tutte 79.388
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.388


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.116 0 0 0 0 0 265 437 263 482 362 162 145
2020/20213.980 240 306 269 276 514 397 232 265 377 347 486 271
2021/20223.239 343 298 215 207 188 179 239 207 387 305 178 493
2022/20233.448 420 306 274 370 361 606 125 206 333 79 239 129
2023/20243.147 111 184 167 151 499 882 149 150 91 157 261 345
2024/20252.277 272 607 172 563 546 117 0 0 0 0 0 0
Totale 25.254